APYX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
APYX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Apyx Medical's yield on cost for the quarter that ended in Dec. 2023 was 0.00.
The historical rank and industry rank for Apyx Medical's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Medical Devices subindustry, Apyx Medical's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Apyx Medical's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Apyx Medical's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Apyx Medical is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Apyx Medical (NAS:APYX) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Apyx Medical's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Todd Hornsby | officer: Executive Vice President | 14321 HAWTHORNE DR., CARMEL IN 46033 |
Goodwin Charles D. Ii | director, officer: Chief Executive Officer | 5115 ULMERTON ROAD, CLEARWATER FL 33760 |
Wendy Lauren Levine | director | 75 KENMARE STREET, APT. 2D, NEW YORK NY 10012 |
Minnie Baylor-henry | director | C/O SCPHARMACUETICALS, INC., 2400 DISTRICT AVENUE SUITE 310, BURLINGTON MA 01803 |
Tara Semb | officer: Chief Financial Officer | 5516 RIVERSIDE HEIGHTS WAY, RICHMOND VA 23225 |
Craig A. Swandal | director | 5115 ULMERTON ROAD, CLEARWATER FL 33760 |
Michael Geraghty | director | 1342 CHERRY HILL ROAD, MENDOTA HEIGHTS MN 55118 |
Lawrence Waldman | director | 5115 ULMERTON RD., CLEARWATER FL 33770 |
John C. Andres | director | 86 CAPRI LANE, CHATHAM MA 02633 |
Jay D. Ewers | officer: Chief Financial Officer | 4 MANHATTANVILLE ROAD, SUITE 106, PURCHASE NY 10577 |
J Robert Saron | director, officer: President | |
Robert Gershon | director, officer: Chief Executive Officer | 5115 ULMERTON ROAD, CLEARWATER FL 33760 |
Mccarthy John J. Iii | officer: Chief CommercializationOfficer | 23 RINALDO ROAD, NORTHPORT NY 11768 |
Scott Richard Davidson | director | C/O GREAT POINT PARTNERS, LLC, 165 MASON STREET, GREENWICH CT 06830 |
Moshe Citronowicz | officer: Vice President of Operations |
From GuruFocus
By Business Wire • 10-02-2023
By Business Wire Business Wire • 08-04-2022
By Business Wire • 01-08-2024
By Business Wire Business Wire • 08-05-2022
By PRNewswire PRNewswire • 05-02-2023
By PRNewswire PRNewswire • 08-05-2022
By PRNewswire PRNewswire • 02-09-2023
By Business Wire Business Wire • 06-14-2023
By Business Wire Business Wire • 02-21-2023
By Business Wire Business Wire • 04-28-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.